| La investigación científica y las formas de titulación C Gómez, G Álvarez, A Romero, F Castro, V Vega, R Comas, ... Aspectos conceptuales y prácticos. Quito: Editorial Jurídica del Ecuador 256, 2017 | 1032 | 2017 |
| Innate immune sensing of modified vaccinia virus Ankara (MVA) is mediated by TLR2-TLR6, MDA-5 and the NALP3 inflammasome J Delaloye, T Roger, QG Steiner-Tardivel, D Le Roy, M Knaup Reymond, ... PLoS pathogens 5 (6), e1000480, 2009 | 380 | 2009 |
| Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19 CE Gómez, B Perdiguero, M Esteban Vaccines 9 (3), 243, 2021 | 264 | 2021 |
| Malformations of the craniocervical junction (Chiari type I and syringomyelia: classification, diagnosis and treatment) A Avellaneda Fernandez, A Isla Guerrero, M Izquierdo Martínez, ... BMC Musculoskeletal disorders 10, 1-11, 2009 | 240 | 2009 |
| The poxvirus vectors MVA and NYVAC as gene delivery systems for vaccination against infectious diseases and cancer CE Gómez, JL Nájera, M Krupa, M Esteban Current gene therapy 8 (2), 97-120, 2008 | 187 | 2008 |
| Escala sobre la ideología del rol sexual M Moya, M Navas, C Gómez Libro de Comunicaciones del III Congreso Nacional de Psicología Social 1 …, 1991 | 179 | 1991 |
| Immunization with HIV Gag targeted to dendritic cells followed by recombinant New York vaccinia virus induces robust T-cell immunity in nonhuman primates BJ Flynn, K Kastenmüller, U Wille-Reece, GD Tomaras, M Alam, ... Proceedings of the National Academy of Sciences 108 (17), 7131-7136, 2011 | 168 | 2011 |
| Comparative analysis of the magnitude, quality, phenotype, and protective capacity of simian immunodeficiency virus gag-specific CD8+ T cells following human-, simian-, and … KM Quinn, A Da Costa, A Yamamoto, D Berry, RWB Lindsay, PA Darrah, ... The Journal of Immunology 190 (6), 2720-2735, 2013 | 126 | 2013 |
| Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV … CE Gómez, JL Nájera, EP Jiménez, V Jiménez, R Wagner, M Graf, ... Vaccine 25 (15), 2863-2885, 2007 | 126 | 2007 |
| Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene JL Nájera, CE Gómez, E Domingo-Gil, MM Gherardi, M Esteban Journal of virology 80 (12), 6033-6047, 2006 | 118 | 2006 |
| Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C CE Gómez, JL Nájera, V Jiménez, K Bieler, J Wild, L Kostic, S Heidari, ... Vaccine 25 (11), 1969-1992, 2007 | 108 | 2007 |
| The HIV/AIDS vaccine candidate MVA-B administered as a single immunogen in humans triggers robust, polyfunctional, and selective effector memory T cell responses to HIV-1 antigens CE Gómez, JL Nájera, B Perdiguero, J García-Arriaza, COS Sorzano, ... Journal of virology 85 (21), 11468-11478, 2011 | 99 | 2011 |
| Differential CD4+ versus CD8+ T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeficiency Virus Type 1 Vaccine Candidates Provide … P Mooij, SS Balla-Jhagjhoorsingh, G Koopman, N Beenhakker, ... Journal of virology 82 (6), 2975-2988, 2008 | 99 | 2008 |
| Poxvirus vectors as HIV/AIDS vaccines in humans C Elena Gomez, B Perdiguero, J García-Arriaza, M Esteban Human vaccines & immunotherapeutics 8 (9), 1192-1207, 2012 | 94 | 2012 |
| Improved NYVAC-based vaccine vectors KV Kibler, CE Gomez, B Perdiguero, S Wong, T Huynh, S Holechek, ... PloS one 6 (11), e25674, 2011 | 91 | 2011 |
| La investigación científica en preguntas y respuestas C Gómez Sistema modular. Corporación uniandes. Ecuador, 2006 | 89 | 2006 |
| Clinical applications of attenuated MVA poxvirus strain CE Gómez, B Perdiguero, J García-Arriaza, M Esteban Expert review of vaccines 12 (12), 1395-1416, 2013 | 86 | 2013 |
| Safety and immunogenicity of a modified pox vector-based HIV/AIDS vaccine candidate expressing Env, Gag, Pol and Nef proteins of HIV-1 subtype B (MVA-B) in healthy HIV-1 … F García, JCLB de Quirós, CE Gómez, B Perdiguero, JL Nájera, ... Vaccine 29 (46), 8309-8316, 2011 | 85 | 2011 |
| Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletions J García-Arriaza, JL Nájera, CE Gómez, COS Sorzano, M Esteban PLoS One 5 (8), e12395, 2010 | 84 | 2010 |
| Aerosol immunization with NYVAC and MVA vectored vaccines is safe, simple, and immunogenic M Corbett, WM Bogers, JL Heeney, S Gerber, C Genin, A Didierlaurent, ... Proceedings of the National Academy of Sciences 105 (6), 2046-2051, 2008 | 84 | 2008 |
